The objective of this study was to compare participation rates and clinical effectiveness of sedated esophagogastroduodenoscopy (sEGD) and unsedated transnasal endoscopy (uTNE) for esophageal assessment and Barrett's esophagus (BE) screening in a population-based cohort.
INTRODUCTION
Th e incidence rate of esophageal adenocarcinoma (EAC) has rapidly risen over the past 3 decades, exceeding that of melanoma, lung, colon, and breast cancers ( 1 ) . Th e 5-year survival remains below 20% for EAC cases diagnosed aft er the onset of symptoms, whereas early-stage EAC has a 5-year survival exceeding 80% ( 2 ). Barrett's esophagus (BE) is the strongest and only known precursor of EAC. However, cancer progression rates in clinically diagnosed BE are as low as 0.33% per year ( 3 ), and hence endoscopic surveillance alone may not have an impact on survival rates from EAC ( 4 ) . Moreover, it is estimated that only a third of patients with BE in the population are detected clinically, with the rest remaining undiagnosed, despite the substantial increase in the use of endoscopy ( 5 ) . Indeed, up to 90% of patients who present with EAC do not have a previous diagnosis of BE ( 6 ) , despite its presence on histology, an indication of the underlying challenge for early detection.
Screening for BE in high-risk individuals coupled with curable endotherapy of early neoplasia may represent an alternative strategy to reduce mortality from this lethal cancer. Th is was endorsed by recent guidelines from gastroenterology societies ( 7, 8 ) . However, several questions remain to be addressed before such an approach can be considered or implemented. To this date, the true population prevalence of BE in the United States remains unknown partly because of the lack of suitable screening tests to replace sedated esophagogastroduodenoscopy (sEGD) for use in the community. Current BE risk prediction models are derived from patients seen at referral centers undergoing endoscopy for clinical indications and may not be representative for use at a population level ( 9, 10 ) . Finally, the lack of real data on participation rates and yield of diff erent screening modalities for assessment in the community limits the validity of assumptions utilized in modeling studies that have found screening to be cost eff ective ( 11 ) .
Unsedated transnasal endoscopy (uTNE) has been proposed as an acceptable and accurate alternative to sEGD for detection of BE ( 12, 13 ) . Th e feasibility and acceptability of this technique was demonstrated in a pilot randomized trial in Olmsted County ( 14 ) . A survey study in this population showed the potential for increased participation if screening was provided closer to home ( 15 ) . Th e EndoSheath transnasal esophagoscope (Vision-Sciences, Orangeburg, NY) has recently become available. It utilizes a novel disposable sheath that encases the endoscope and completely isolates it from patient contact, obviating the need for decontamination and reprocessing facilities. It utilizes a more compact processing system allowing for easy portability, rendering it suitable for widespread use. Initial reports on the clinical utility of this device in an offi ce-based setting have been encouraging ( 16 ) .
Th e comparative clinical eff ectiveness of uTNE compared with sEGD in community screening for BE, specifi cally participation rates, diagnostic yield, tolerability, and safety, has not been studied before. Although previous studies have used either uTNE alone or in tandem with sEGD ( 12, 16 ) , this does not allow a simultaneous and systematic comparison of both approaches separately. Furthermore, the clinical utility and eff ectiveness of using a mobile van unit for screening with uTNE closer to the patient's home also remains unknown.
Th e aims of our study were: (i) to assess participation rates in BE screening using uTNE in a mobile van unit (muTNE), uTNE in a hospital endoscopy unit (huTNE), and conventional sEGD and (ii) to compare the clinical eff ectiveness of these techniques in a population-based randomized trial.
METHODS

Trial design and settings
Th is was a prospective, randomized, controlled trial conducted in Olmsted County, MN, USA. Th e study took place between 1 April 2011 and 30 October 2013. Th e Olmsted County population comprises ∼ 144,000 individuals of whom 86% are white (2010 US Census data). County residents receive their medical care almost exclusively from two group practices: the Mayo Medical Centre and Olmsted Medical Center. Th e Mayo Clinic has maintained a common medical record system with its two affi liated hospitals. Th e system was further developed by the Rochester Epidemiology Project that created indices for the records of other providers of medical care to local residents. Annually, over 80% of the entire population is attended by one or both of these two practices, and nearly everyone is seen at least once during any given 4-year period ( 17 ) . Th erefore, the Rochester Epidemiology Project medical records linkage system provides an enumeration of the population from which samples can be drawn. All participants gave informed consent and the study received approval from the Mayo Clinic and Olmsted Medical Center Institutional Review Boards. Th e trial was registered on clinicaltrials.gov (identifi er: NCT01288612).
Participants
Using the Rochester Epidemiology Project resources, age-and gender-stratifi ed random samples of Olmsted County residents were previously drawn, and those subjects were mailed validated gastrointestinal symptom questionnaires from 1988 to 2009 ( 5, 18, 19 ) . Th ose population-based surveys have allowed identification of a cohort of community subjects, well characterized by the frequency of refl ux symptoms.
Eligible subjects were ≥50 years old with no previous history of endoscopic evaluation and not known to have BE. In this cohort ( n =1,157), individuals were randomized-stratifi ed by age, sex, and refl ux symptoms-and assigned to muTNE, huTNE, or sEGD groups. Within each group, patients were sorted in a random order, and an initial sample of 450 potential participants was obtained (150 per group) to contact for recruitment to the study. Medical chart review was performed to check for exclusion criteria, namely: history of progressive dysphagia, known Zenker's or epiphrenic diverticulum, history of recurrent epistaxis, moved out of Olmsted County or deceased, signifi cant illness that may impair ability to complete questionnaires (e.g., metastatic cancer, major stroke, and dementia), and coagulopathy.
Successive patients who met the inclusion and exclusion criteria in each of the three groups were initially sent generic invitation letters asking if "they agree to be contacted by phone in two weeks' time to inform them about a research study run by Mayo Clinic. " Subjects who explicitly declined to be contacted regarding research were excluded from the study, and others who agreed or did not respond aft er 2 weeks were considered eligible to be contacted. Details of patient fl ow are shown in Figure 1 .
Eligible patients received a telephone call from a research coordinator who was blinded to the primary hypothesis of the study. One of three standardized telephone scripts were used depending on the group assignment. Subjects were only off ered the technique that they had been randomized to. Th ese scripts included information on the rationale of the study and details on the procedure and its potential adverse eff ects (see Supplementary Material online). In each group, the order for contacting patients was randomized. Patients who declined participation or could not be reached by telephone aft er three attempts were not further contacted. Patients in all three3 groups were treated and followed up in the same manner.
Interventions
Before endoscopic procedures, participants filled out the gastroesophageal reflux questionnaire ( 18 ) , a validated measure of reflux and somatic symptoms. Reflux symptoms were classified into: frequent (≥one episode/week of heartburn or acid regurgitation), infrequent (<one episode/week of heartburn or acid regurgitation), or absent (no heartburn or acid regurgitation).
Th e sEGD procedures were performed using a conventional high-defi nition endoscope (GIF-180, Olympus America, Center Valley, PA) under conscious sedation with intravenous midazolam and fentanyl. Th e uTNE was performed using the EndoSheath transnasal esophagoscope (TNE-5000, Vision-Sciences). Th e working length is 650 mm with 140° up and 215° down tip defl ection and 120° fi eld of view. Th e insertion diameter is 4.7 mm when using a sheath with no working channel, and this increases to 5.4 or 5.8 mm when using a sheath containing 1.5 or 2.1 mm working channel, respectively. All procedures were performed by expert gastroenterologists who had performed over 1,000 upper gastrointestinal endoscopic examinations. Topical anesthetic aerosol spray (Benzocaine 20%; Topex, Sultan Healthcare, Hackensack, NJ) was applied to the posterior pharynx and nasal spray mixture (Phenylephrine 1.0%, Leader, Cardinal Health, Dublin, OH; and Lidocaine 4%, Hospira, Lake Forest, IL) was applied to the patient's nares (6-8 sprays) 10-15 min before uTNE.
The uTNE procedure was performed with the patient lying in the left lateral position. The endoscope was introduced into the right or left nares and advanced into the proximal esophagus under direct vision. Before every procedure, the esophagoscope was placed inside a new, sterile sheath. Following the procedure, the esophagoscope was removed from the sheath, which is then discarded, and the endoscope was cleaned with a 70% ethyl alcohol wipe and an enzymatic detergent after every use.
Th e muTNE group underwent the research procedures in a mobile research vehicle that is staff ed by a registered nurse. Th e mobile research vehicle contains two exam rooms with cardiorespiratory monitoring equipment, a private area for patient interviews, and audiovisual technology for patient education ( Figure 2 ). Eligible subjects were divided into four groups geographically 
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in Olmsted County (on the basis of residential address: northwest, northeast, southwest, and southeast quadrants) and were approached consecutively by group. Screening exams in this group were conducted in the exam room space, in sets of 5-6 subjects to maximize effi ciency. Once fi ve subjects consented to participate in this arm of the study, the mobile research vehicle was driven to a geographical location in close proximity to the subjects' residence and stationed in a suitable area with convenient parking. A maximum of six screening procedures were conducted in one muTNE session over a 4-5 h period. Fift een sessions were conducted to screen 76 subjects. Biopsies were taken from any endoscopically suspected BE and from the gastroesophageal junction and squamous mucosa in all subjects. Th e length of BE segment was defi ned using the Prague criteria ( 20 ) . All participants received a telephone call from the research coordinator 1 and 30 days aft er the procedure to complete validated tolerability scales ( 21 ) and adverse events questionnaires.
Outcome measures
Th e primary outcome measure was participation rate. Th is was estimated as the proportion of subjects who agreed to undergo esophageal assessment in the three groups (muTNE, huTNE, and sEGD) out of those who were eligible to be contacted for participation in screening. Additional analysis was performed to identify clinical and demographic factors associated with higher participation rates in screening.
Th e secondary outcome measure was clinical eff ectiveness. Th is was evaluated by assessing both the quality and yield of esophageal assessment with muTNE, huTNE, and sEGD. All parameters were recorded by the trial coordinator for all procedures.
Th e end points for procedure quality were: rate of successful intubation (the ability to traverse the upper esophageal sphincter and visualize the esophageal mucosa) classifi ed as successful or unsuccessful; rate of complete evaluation (visualization of the whole esophagus and identifi cation of landmarks: squamocolumnar junction, gastroesophageal junction (upper margin of gastric folds with stomach defl ated), and the diaphragmatic hiatus) classifi ed as complete (all three landmarks identifi ed), incomplete (some landmarks identifi ed), or unsuccessful; rate of successful acquisition of biopsies scored as successful (all biopsies obtained), incomplete (some biopsies are obtained), or unsuccessful (no biopsies can be obtained); duration of procedure in min (time from the beginning of procedure (initiation of sedation or local anesthesia) to extubation, and time from extubation to discharge (recovery time)); tolerability (validated pain scales ( 21 )-where "0" is none and "10" is severe-were used to assess the degree of pain, choking, gagging, and anxiety experienced during the procedure, and overall tolerance was rated on a scale from 0 to 10, where "0" is good and "10" is poor tolerance); acceptability (proportion of patients willing to undergo the procedure again in the future); safety (adverse events including pain, abdominal discomfort, bleeding, perforation, or need for hospitalization) assessed 1 and 30 days aft er the procedures in all subjects.
End points for procedure yield included: refl ux esophagitis (graded using the Los Angeles classifi cation ( 22 ) ); suspected BE (presence of columnar mucosa at least 1 cm length in the tubular esophagus); and confi rmed BE (presence of intestinal metaplasia with goblet cells in biopsies on hematoxylin and eosin stains). All patients with suspected BE in the muTNE and huTNE groups were off ered a "confi rmatory" clinical sEGD with histology in 2-week time. Histology was interpreted by a gastrointestinal pathologist blinded to the cohort assignment.
Randomization and sample size estimation
Subjects eligible to be contacted were randomly assigned to one of three procedures (muTNE, huTNE, and sEGD) stratifi ed by sex, presence of gastroesophageal refl ux disease, and age group (≥65 vs. <65 years). Th e assignments were generated via a computer algorithm (SAS, SAS Institute, Cary, NC) by the study statistician and sent to the study coordinator via an EXCEL spreadsheet (Excel 2010, Microsoft , Redmond, WA).
In a prior pilot study done by us ( 14 ) , the participation rate for using sEGD was 37% compared with 47% for uTNE. A sample size of 150 subjects (eligible to be invited for participation) in each group provided 80% power to detect a 20% increase in screening participation using uTNE (thought to be clinically signifi cant) over sEGD, using a two-sample test of proportions at an α -level of 0.0125, accounting for four comparisons ((i) sEGD vs. huTNE, (ii) teristics. Given the need for multiple comparisons to assess this hypothesis, statistical signifi cance was defi ned using an α -level of 0.01 (adjusting for testing multiple measures of performance). Th e statistical soft ware (SAS version 9.3) was used for analysis.
RESULTS
Participation rates and predictors
A total of 459 subjects were eligible to be contacted and invited for screening in their allocated study arm (muTNE n =158, huTNE n =151, and sEGD n =150). In this cohort, 43 (9.4%) had frequent refl ux symptoms (≥1/week), 197 (42.9%) had infrequent symptoms (<1/week), and 219 (47.7%) had no refl ux symptoms. Baseline characteristics were comparable among the three groups ( Table 1 ) .
Of the 459 subjects contacted, 209 (46%) agreed to undergo study procedures (muTNE n =76, huTNE n =72, and sEGD n =61). Th e mean (±s.d.) age of this cohort of "participants" was 65 years (±9) and 45.9% were males. In this cohort, 29 (13.9%) had frequent refl ux symptoms, 86 (41.1%) had infrequent symptoms, and 90 (43%) had no refl ux symptoms. Baseline characteristics were also comparable among the three groups of participants ( Table 2 ). sEGD vs. muTNE, (iii) sEGD vs. huTNE and muTNE combined, and (iv) huTNE vs. muTNE).
Statistical analysis
Pairwise comparisons of participation proportions in the three study arms were assessed. Th ese proportions were compared using the χ 2 test (or Fisher's exact test as appropriate). Logistic regression analysis was utilized to identify factors predicting participation. Several logistic regression models were examined, each one including the procedure group and one of a fi xed ( a priori selected) set of predictor variables to identify factors associated with participation in screening. We assessed the following a priori selected variables: age, gender, education level, employment, marital status, refl ux symptoms, use of proton pump inhibitor drugs, randomization group, somatic symptom checklist score, and Charlson comorbidity index.
Th e performance characteristics and yield of muTNE, huTNE, and sEGD were summarized either as proportions (95% confidence intervals) for categorical characteristics, or as mean (s.d.) or median (interquartile range) depending on their distribution for continuous characteristics. Th ese characteristics were compared across the three groups using the Kruskal-Wallis test for the continuous characteristics and the χ 2 test for categorical charac- 
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Although participation rates were numerically higher in the unsedated arms of muTNE (48.1%) and huTNE (47.7%) compared with the sEGD arm (40.7%), these diff erences were not statistically signifi cant on pairwise comparisons (sEGD vs. muTNE, P =0.25; sEGD vs. huTNE, P =0.42; sEGD vs. muTNE or huTNE, P =0.27; muTNE vs. huTNE, P =0.82). Factors that independently predicted higher participation rates included presence of frequent refl ux symptoms (odds ratio 2.94, 95% confi dence interval 1.47-5.88) and being either unemployed or a homemaker (odds ratio 2.48, 95% confi dence interval 1.07-5.77). Age, gender, education level, marital status, current proton pump inhibitor drug use, somatic symptom checklist score, and Charlson comorbidity index were not associated with signifi cant diff erences in participation rates ( Table 3 ).
Quality and yield of endoscopic assessment
Complete evaluation of the esophagus (intubation, visualization of the mucosa, and landmark identifi cation) was comparable using muTNE ( n =75, 98.7%), huTNE ( n =69, 95.8%), and sEGD ( n =61, 100%) techniques ( P =0.08). However, successful biopsy acquisition was lower in the muTNE ( n =60, 79%) and huTNE ( n =60, 83.3%) groups compared with sEGD ( n =61, 100%) ( P =0.001). Th is was because of the inability to intubate the nasopharynx using the larger diameter sheath (5.8 mm) that contains the biopsy channel. Hence, in all these cases, the endoscopist attempted intubation using the smaller diameter sheath (4.7 mm) with no biopsy channel to facilitate the intubation and visualization of the esophagus without obtaining biopsy samples. Recovery times (from extubation to discharge) were signifi cantly longer aft er sEGD (67.3±5.9) compared with muTNE (15.5±2.8) and huTNE (18.5±4.2) techniques ( P <0.001).
Although the overall tolerability scores (mean±s.d.) for sEGD was better than muTNE and huTNE (0.4±0.6 vs. 1.9±2.2 and 2.2±2.2 respectively, P <0.001), uTNE was overall well tolerated. Moreover, a substantial majority of patients undergoing muTNE and huTNE were willing to undergo TNE again (78.9 and 83.3%, respectively, compared with 93% with sEGD). No was C0 (range 0-8) and M2 (range 1-10). One patient was found to have low-grade dysplasia and one patient was diagnosed with high-grade dysplasia. Th e rates of detection of manifestations of gastroesophageal refl ux disease-induced esophageal injury in subjects with and without refl ux symptoms are shown in Table 5 . Erosive esophagitis was seen in several subjects with refl ux symptoms (35%, 17% Los Angeles (LA) grades B and C) and without refl ux symptoms (23%, 10% LA grades B and C).
serious adverse events were reported in any of the three arms ( Table 4 ) . Th ere was no diff erence in procedure yield among the three study arms with regard to suspected ( P =0.37) and confi rmed ( P =0.44) BE. However, the yield for erosive esophagitis was higher in the huTNE and sEGD arms compared with muTNE ( P =0.003). Overall, 16 subjects (5 females and 11 males) were diagnosed with BE (7.8%). Median segment length (using Prague classifi cation) was higher in those with frequent and infrequent refl ux symptoms (10%), it was also substantial on those without refl ux symptoms (4.4%).
Unsedated TNE has been shown to be an accurate alternative to sEGD for the diagnosis of BE ( 12, 13 ) . However, comparative data on technical success rate, tolerability, and acceptability of uTNE with respect to sEGD in the population are lacking. Although uTNE screening was found to be more cost eff ective than screening using sEGD ( 11 ) , assumptions such as a 95% participation rate in screening were used. Our study provides the fi rst real data on participation and completion rates of uTNE in the community, in addition to demonstrating the comparable clinical eff ectiveness of uTNE to sEGD. Although a substantial majority of patients who underwent muTNE and huTNE were willing to undergo the test again in future if necessary (78.9% and 83.3%, respectively), acceptability of sEGD was signifi cantly higher (93.4%, P =0.001). It is likely that the use of sedation for sEGD may explain this as it makes the procedure more comfortable to patients, and likely impairs memory and recollection of the event.
Mobile screening vans have been found to be eff ective instruments in increasing population participation in screening (in and outside the United States) for cervical ( 31 ) , colon ( 32 ) , breast ( 33 ) , and lung ( 34 ) cancers, with no decrement in accuracy and in a cost-eff ective manner ( 35 ) . A survey study conducted by us previously suggested that participation in BE screening may increase by the use of mobile screening ( 15 ) . Th erefore, we elected to evaluate this technique by incorporating the portable and disposable EndoSheath system in a mobile research van,. We did not fi nd a statistically signifi cant increase in uptake rates between the hospital and mobile TNE arms. Th is may be a result of the excellent access to medical care and endoscopy in Olmsted County and should be tested in more medically underserved populations with limited access to screening tests. Despite this, an important fi nding of our study was the reduction in recovery and overall patient visit duration achieved by using the muTNE and huTNE techniques compared with sEGD, without any substantial decrement in yield, tolerability, and safety. Furthermore, uTNE can be performed by nongastroenterology physicians as well as by physician extenders, raising the possibility of this being a truly community-based screening tool ( 36 ) .
Successful biopsy acquisition remains a limitation of the current uTNE device. Th is was lower in the muTNE (79%) and huTNE (83.3%) groups compared with sEGD (100%) ( P =0.001), primarily because of inability to intubate the esophagus with the larger sheath containing the biopsy channel. In all those cases, the endoscopist switched to the thinner biopsy channel-free sheath to enable intubation and visualization of the esophagus. If screening is to be implemented in practice, then the issue of biopsy acquisition using uTNE becomes less important because all subjects with endoscopically suspected BE on uTNE will likely require a clinical sEGD for surveillance biopsies ( 7 ) .
Th ere was a higher yield of erosive esophagitis with the hospital-based techniques compared with the mobile technique. Th e reasons for this remain unclear, in particular, as the proportion of
DISCUSSION
We report results from the fi rst large prospective randomized trial evaluating novel approaches to assess gastroesophageal refl ux disease complications (including BE) in a population cohort in the United States. In this study we have demonstrated comparable participation rates, clinical eff ectiveness, and safety of unsedated TNE (performed in both the hospital and a mobile setting) to sedated EGD for the assessment of gastroesophageal refl ux disease complications. Although the participation rates were numerically higher in the unsedated techniques (muTNE and huTNE) compared with sEGD, the diff erence was not statistically signifi cant. Th e patient's visit was signifi cantly shorter using uTNE techniques with adequate tolerability and acceptability. Patients with frequent heartburn or acid regurgitation were signifi cantly more likely to participate in screening compared with those with infrequent or no refl ux symptoms. Th e overall proportion of subjects in the study population who had BE was 7.8%, with 4.4% of subjects without refl ux symptoms being diagnosed with BE.
In this study, subjects were randomized and off ered their allocated screening test only, as opposed to off ering all three to every patient (with the patient choosing the technique). Th is design was chosen in order to obtain comparative and valid estimates of participation rates for each one of the three techniques separately. Results from this study are concordant with the previous pilot trial comparing uTNE, video capsule endoscopy, and sEGD screening ( 14 ) . Although video capsule endoscopy was the most acceptable in that study, given its suboptimal accuracy for the detection of BE ( 23 ), this technique was not assessed in this study.
Development of noninvasive screening tests over the past few years have led to renewed interest in screening for BE and EAC. Th e Cytosponge™ (PA consulting, Melbourn, UK and Europlaz, Southminster, UK) is a capsule cell-sampling device, coupled with a biomarker ( 24 ) . In a primary care study involving 12 UK general practices, 18% of invited subjects agreed to take part. Th e sensitivity and specifi city of the test for the detection of Barrett's epithelium was 73.3 and 93.8% ( 24 ) . Of the participants, 3.0% (15/501) had a confi rmed diagnosis of BE. Cytosponge™ screening was also found to be cost eff ective in a recent economic modeling study ( 25 ) . Th is device is promising given its low cost and potential widespread applicability. Nonetheless, it is a nonendoscopic technique and hence will still need a confi rmatory endoscopy.
BE prevalence rates between 6 and 25% have been reported from the US referral center cohorts ( 26, 27 ) . Population studies from Europe have reported lower prevalence (1.3-1.6%) for BE ( 28, 29 ) . Th is may refl ect diff erences in risk factors such as obesity, Helicobacter pylori , and diff erences in endoscopic and histological assessment ( 30 ) . Th e reasons for higher BE prevalence in our study (7.6%) compared with the Cytosponge™ study are not fully clear. Participants in both studies had comparable sociodemographic characteristics but all patients in the Cytosponge™ study had a history of refl ux symptoms or receiving acid-suppressive medication prescriptions. Participation rates in this study were substantially higher than in the Cytosponge™ study. Although prevalence of BE ESOPHAGUS Screening for BE: A Randomized Community Trial subjects with refl ux symptoms and other baseline characteristics were comparable across the three study arms. Better visualization of the esophagus in studies conducted in the hospital may be a potential explanation.
Th is study provides an insight into the potential subset of undetected BE in the community ( 37 ) and helped us to determine the acceptability of screening in a previously untested segment of the population. Given the demographic make-up of Olmsted County, our study sample is representative of the US white population, the likely target population for future screening eff orts for BE and EAC. However, it remains to be seen whether these fi ndings are generalizable to the rest of the US population, given the educational and socioeconomic status of the population studied. Although response bias is a possibility because the cohort consisted of responders to previous health questionnaires, this is unlikely because of the lack of diff erence between responders and nonresponders that has been demonstrated in this population ( 38 ) .
In conclusion, in this prospective, randomized, populationbased study utilizing state-of-the-art novel minimally invasive endoscopic techniques in a hospital and mobile setting, we demonstrate comparable clinical eff ectiveness, safety, and participation rates with uTNE. Th is is likely dependent on clinical uTNE being performed more effi ciently than in the research setting. Data from this study may help inform future economic and risk stratifi cation modeling studies. BE and esophagitis prevalence in the community is substantial, in both those with and without refl ux symptoms.
